| Monitoring prioritisation in the public health-care sector by use of medical guidelines. The case of Norway. | |
| | |
MedLine Citation:
|
PMID: 20853521 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
This paper presents a new way to monitor priority settings in public health-care systems. We take departure in medical guidelines prescribing acceptable waiting times for different medical descriptions. Allocating ICD10 codes to the medical descriptions, we are able to compare actual waiting times to the recommended maximum waiting times. This way we use the medical guidelines as a tool for monitoring prioritisation in the health sector. In an application, using data from the Norwegian Patient Register, we test statistically for compliance with the guidelines. The results indicate that patients suffering from the most severe conditions are receiving too low priority in the Norwegian health-care sector relative to patients of lower priority. Copyright © 2010 John Wiley & Sons, Ltd. |
| | |
Authors:
|
Jan Erik Askildsen; Tor Helge Holmås; Oddvar Kaarboe |
Publication Detail:
|
Type: Journal Article Date: 2010-09-20 |
Journal Detail:
|
Title: Health economics Volume: 20 ISSN: 1099-1050 ISO Abbreviation: Health Econ Publication Date: 2011 Aug |
Date Detail:
|
Created Date: 2011-07-04 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9306780 Medline TA: Health Econ Country: England |
Other Details:
|
Languages: eng Pagination: 958-70 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 John Wiley & Sons, Ltd. |
Affiliation:
|
Uni Rokkansenteret and Health Economics Bergen, HEB, Norway. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The male-female gap in physician earnings: evidence from a public health insurance system.
Next Document: Carbon nanotube-coupled cell adhesion peptides are non-immunogenic: a promising step toward new biom...